Bill > LD1053

This bill modifies existing insurance regulations regarding prescription drug manufacturer rebates, primarily focusing on how these rebates are handled by carriers and pharmacy benefits managers (PBMs). The bill removes a previous provision that allowed carriers to retain rebates and instead mandates that pharmaceutical manufacturer compensation must be passed directly to patients at the point of sale to reduce their out-of-pocket prescription drug costs. PBMs and carriers are now required to file an annual report with the Superintendent of Insurance by March 1st, demonstrating their compliance with these new requirements. The legislation also authorizes the superintendent to impose civil penalties and take enforcement actions against carriers or PBMs that do not comply with the new rules. Additionally, the bill designates the information submitted in these reports as confidential and explicitly states that the law does not interfere with federal drug discount requirements for covered entities under existing federal regulations. The primary goal of this bill is to ensure that patients directly benefit from manufacturer rebates by lowering their immediate prescription costs at the pharmacy.

Health and Social Services

https://legislature.maine.gov/legis/bills/display_ps.asp?LD=1053&snum=132